Rilpivirine is used to treat human immunodeficiency virus (HIV) infection. HIV is the virus that causes acquired immune deficiency syndrome (AIDS). This medicine is usually given to patients who have not received any HIV treatment in the past. Rilpivirine is a non-nucleoside reverse transcriptase inhibitor. It is grouped under the following drug class(es): Reverse Transcriptase Inhibitors. Its therapeutic use is listed as anti-infectives and antivirals. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Edurant(TM), Rekambys (TN) and TMC-278. Its PubChem CID is 6451164.
Rilpivirine
| CAS No | 500287-72-9 |
|---|---|
| Molecular Formula | C22H18N6 |
| Molecular Weight | 366.4 g/mol |
| Synonyms | 4-[[4-[4-[(E)-2-cyanoethenyl]-2,6-dimethylanilino]pyrimidin-2-yl]amino]benzonitrile |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Rilpivirine is used to treat human immunodeficiency virus (HIV) infection. HIV is the virus that causes acquired immune deficiency syndrome (AIDS). This medicine is usually given to patients who have not received any HIV treatment in the past.
The listed CAS number is 500287-72-9.
The listed molecular formula is C22H18N6.
The listed molecular weight is 366.4 g/mol.
4-[[4-[4-[(E)-2-cyanoethenyl]-2,6-dimethylanilino]pyrimidin-2-yl]amino]benzonitrile.
The source lists Edurant(TM), Rekambys (TN) and TMC-278.